Approach
Patient partners in a sector that needs them.
Colombia’s cannabis industry didn’t fail for lack of land or light. It stalled on evidence, certification and trust. Our approach is built to supply exactly those, one verified step at a time.
How we work
Four stages, each earned by the one before.
- 01
Research Now
We map Colombia’s licence holders from the official registers, verify who is genuinely operating, and document what regulated buyers in Germany, the UK and Australia require. Everything is sourced and dated.
Outcome: A verified picture of the market: who is licensed, who is active, and what “ready” really means.
- 02
Qualification Next
With a small number of operators, we work through the evidence a serious partner would ask for: licences and quota, GACP practice, documentation, governance and the route to EU-GMP processing.
Outcome: A clear, honest readiness assessment, and a plan to close the gaps.
- 03
Partnership Later
Where interests align, we commit for the long term through milestone-based partnerships agreed in writing and reviewed by independent counsel in the UK and Colombia.
Outcome: Aligned incentives: we succeed only when the operator does.
- 04
Compliant growth Long term
The operating company, not Cordavira, cultivates and supplies authorised downstream participants under its own licences. Our role is to help it become the kind of producer regulated markets can rely on.
Outcome: A producer with the evidence to earn and keep regulated customers.
Compliance
Legal review comes before activity, not after.
Medical cannabis sits under controlled-drug law in every market we study. That shapes everything we do.
- We take independent legal advice in both the UK and Colombia before starting any new type of activity.
- We do not handle, store, transport, sell or broker cannabis, and we take no commission on any controlled-drug transaction.
- We separate claims from evidence. If an operator says it holds a certificate, we record that as a claim until we have seen it.
- Our partners cultivate and supply under their own licences. Cordavira never presents itself as a supplier.
Where we look
Colombia first. Regulated markets in view.
Colombia is our home market for partnership: equatorial light, altitude and a deep pool of licensed growers. We study destination markets so we know what “ready” means before an operator spends money chasing it.
Germany
Europe’s largest medical cannabis market, with established import and pharmacy channels.
United Kingdom
Prescription-only supply through licensed importers, wholesalers and specialist prescribers.
Australia
A mature prescription and import framework regulated by the TGA and Office of Drug Control.
Poland & Czechia
Growing European medical programmes, each with its own country-specific rules.
Portugal
A benchmark for EU cultivation and processing, regulated by INFARMED.